1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息，点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏，就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据，助力企业精准决策，把握市场增长，就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Insulin lispro Sanofi | insulin lispro | 赖脯胰岛素 | A10AB04 | 2017-07-19 | Sanofi Winthrop Industrie | Authorised |
| Herzuma | trastuzumab | 曲妥珠单抗 | L01XC03 | 2018-02-09 | Celltrion Healthcare Hungary Kft. | Authorised |
| Noxafil | posaconazole | 泊沙康唑 | J02AC04 | 2005-10-25 | Merck Sharp and Dohme B.V | Authorised |
| Ultomiris | ravulizumab | 瑞利珠单抗 | L04AA43 | 2019-07-02 | Alexion Europe SAS | Authorised |
| Imcivree | setmelanotide | 醋酸塞美兰肽 | A08AA | 2021-07-16 | Rhythm Pharmaceuticals Netherlands B.V. | Authorised |
| Synagis | palivizumab | 帕利珠单抗 | J06BD01 | 1999-08-13 | AstraZeneca AB | Authorised |
| Evicel | human fibrinogen;human thrombin | 人纤维蛋白原;人凝血酶 | B02BC | 2008-10-05 | Omrix Biopharmaceuticals N. V. | Withdrawn |
| MicardisPlus | 氢氯噻嗪;替米沙坦 | C09DA07 | 2002-04-19 | Boehringer Ingelheim International GmbH | Authorised | |
| Lamivudine/Zidovudine Teva | lamivudine;zidovudine | 拉米夫定;齐多夫定 | J05AR01 | 2011-02-28 | Teva Pharma B.V.xa0 | Withdrawn |
| Vihuma | simoctocog alfa | 塞莫凝血素α | B02BD02 | 2017-02-13 | Octapharma AB | Authorised |
| Nuwiq | simoctocog alfa | 塞莫凝血素α | B02BD02 | 2014-07-22 | Octapharma AB | Authorised |
| Beyfortus | nirsevimab | 尼塞韦单抗 | J06BD08 | 2022-10-31 | Sanofi Winthrop Industrie | Authorised |
| Elocta | efmoroctocog alfa | 艾莫凝血素-8α | B02BD02 | 2015-11-18 | Swedish Orphan Biovitrum AB (publ) | Authorised |
| Inrebic | fedratinib | 盐酸菲卓替尼 | L01EJ02 | 2021-02-08 | Bristol Myers Squibb Pharma EEIG | Authorised |
| Vydura | rimegepant | 硫酸瑞美吉泮 | N02CD06 | 2022-04-25 | Pfizer Europe MA EEIGxa0 | Authorised |
| Flucelvax Tetra | influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | J07BB02 | 2018-12-12 | Seqirus Netherlands B.V. | Authorised | |
| Revatio | sildenafil | 枸橼酸西地那非 | G04BE03 | 2005-10-28 | Upjohn EESV | Authorised |
| Symtuza | darunavir;cobicistat;emtricitabine;tenofovir alafenamide | J05AR22 | 2017-09-21 | Janssen-Cilag International NV | Authorised | |
| Ecalta | anidulafungin | 阿尼芬净 | J02AX06 | 2007-09-20 | Pfizer Europe MA EEIG | Authorised |
| Lucentis | ranibizumab | 雷珠单抗 | S01LA04 | 2007-01-22 | Novartis Europharm Limited | Authorised |
